Abstract
Sleep disturbances are very common in cancer patients. They are part of a symptom cluster with fatigue and pain that greatly affect quality of life in these patients. Lung cancer patients are found to have the highest prevalence of sleep disturbances. However, these disturbances have not been as well-studied in the lung cancer patients. Though insomnia is the most common disorder seen in these patients, other sleep disorders like excessive daytime sleepiness, limb movement disorders and circadian rhythm disorders have also been described. Treatment of these disorders may affect the prognosis of patients with lung cancer. More studies should be done to elucidate the details of sleep disturbances in lung cancer patients.
Keywords: Lung cancer and sleep disturbances, insomnia and lung cancer, restless legs syndrome and cancer
Current Respiratory Medicine Reviews
Title: Sleep Disturbances in Lung Cancer Patients
Volume: 5 Issue: 4
Author(s): Kanta Velamuri
Affiliation:
Keywords: Lung cancer and sleep disturbances, insomnia and lung cancer, restless legs syndrome and cancer
Abstract: Sleep disturbances are very common in cancer patients. They are part of a symptom cluster with fatigue and pain that greatly affect quality of life in these patients. Lung cancer patients are found to have the highest prevalence of sleep disturbances. However, these disturbances have not been as well-studied in the lung cancer patients. Though insomnia is the most common disorder seen in these patients, other sleep disorders like excessive daytime sleepiness, limb movement disorders and circadian rhythm disorders have also been described. Treatment of these disorders may affect the prognosis of patients with lung cancer. More studies should be done to elucidate the details of sleep disturbances in lung cancer patients.
Export Options
About this article
Cite this article as:
Velamuri Kanta, Sleep Disturbances in Lung Cancer Patients, Current Respiratory Medicine Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339809790112500
DOI https://dx.doi.org/10.2174/157339809790112500 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Patents on Morphometric Analysis of Eukaryotic Cells
Recent Patents on Medical Imaging Quinoline Derivatives: Candidate Drugs for a Class B G-Protein Coupled Receptor, the Calcitonin Gene-Related Peptide Receptor, a Cause of Migraines
CNS & Neurological Disorders - Drug Targets Muscarinic Receptors as Targets for Metronomic Therapy in Breast Cancer
Current Pharmaceutical Design Comparison of Mono-dopaminergic and Multi-target Pharmacotherapies in Primary Parkinson Syndrome and Assessment Tools to Evaluate Motor and Non-motor Symptoms
Current Drug Therapy Toward a Developmentally Centered Approach to Adolescent Alcohol and Substance Use Treatment
Current Drug Abuse Reviews Imaging in Diabetic Retinopathy: A Review of Current and Future Techniques
Current Diabetes Reviews Neuropharmacology of Vestibular System Disorders
Current Neuropharmacology LRP/LR as an Alternative Promising Target in Therapy of Prion Diseases, Alzheimers Disease and Cancer
Infectious Disorders - Drug Targets Role of Diagnostic Ultrasound in Patient Selection for Stroke Intervention
Recent Patents on CNS Drug Discovery (Discontinued) Nodulisporic Acid: Its Chemistry and Biology
Current Topics in Medicinal Chemistry Spatiotemporal Gait Characteristics Associated with Cognitive Impairment: A Multicenter Cross-Sectional Study, the Intercontinental “Gait, cOgnitiOn & Decline” Initiative
Current Alzheimer Research Going up in Smoke? A Review of nAChRs-based Treatment Strategies for Improving Cognition in Schizophrenia
Current Pharmaceutical Design Phosphodiesterase as a New Therapeutic Target for the Treatment of Spinal Cord Injury and Neurodegenerative Diseases
Current Medicinal Chemistry Effect of Brain Derived Neurotrophic Factor (BDNF) Gene Variants on Therapeutic Response and the Risk for Schizophrenia
Current Pharmacogenomics Late-Onset Glycogen Storage Disease Type 2
Current Molecular Medicine Active Form of Neuroprotective Humanin, HN, and Inactive Analog, S7AHN, are Monomeric and Disordered in Aqueous Phosphate Solution at pH 6.0; No Correlation of Solution Structure with Activity
Protein & Peptide Letters Role of Neuronal Guidance Cues in the Pathophysiology of Obesity: A Peripheral and Central Overview
Current Pharmaceutical Design Analysis of Homocysteine in Plasma of Rats Exposed to High-fat Diet and Chronic Unpredictable Mild Stress by LC/ESI-MS/MS
Current Analytical Chemistry Food Fortification with Omega-3 Fatty Acids; Microencapsulation as an Addition Method
Current Nutrition & Food Science Membrane Interacting Peptides: A Review
Current Protein & Peptide Science